| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_600ab8cffe72eeca586ef3ba3d70a10a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1320883cb0fbbb5d6c52d2da580e504f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43319dd4a750f0ae8cbf67960c77326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7824048d160f6f18532992a498d78131 |
| publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-343014-B |
| titleOfInvention |
SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS INDUCTIVE AGENT. |
| abstract |
Crystalline salts and forms of 4- (4 - {[2- (4-chlorophenyl) -4,4-dimethylcyclohex-1-en-1-iI] methyl} piperazin-1-yl) -N - ({3 -nitro-4 - [(tetra hydro-2H-pyran-4-ylmethyl) amino] phenyl} sulfonyl) -2- (1H-pyrrolo [2,3- b] pyridin-5-yloxy) benzamide are appropriate active pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of a disease characterized by overexpression of one or more anti-apoptotic proteins of the Bcl-2 family, for example cancer. |
| priorityDate |
2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |